Cargando…
Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder
Omeprazole, a proton pump inhibitor (PPI), has widely been used to treat various gastrointestinal (GI) disorders. Notably, many clinical symptoms of GI disorders have been known to be associated with anxiety. In recent years, an exponentially increased number of subjects with abnormal ageing, neurol...
Autores principales: | Sri Rethinavel, Harini, Selvaraj, Divya Bharathi, Balakrishnan, Sathya Jeevitha, Vergil Andrews, Jemi Feiona, Joseph, Jerly Helan Mary, Kandasamy, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253648/ https://www.ncbi.nlm.nih.gov/pubmed/35800723 http://dx.doi.org/10.1016/j.heliyon.2022.e09787 |
Ejemplares similares
-
Ranitidine Alleviates Anxiety-like Behaviors and Improves the Density of Pyramidal Neurons upon Deactivation of Microglia in the CA3 Region of the Hippocampus in a Cysteamine HCl-Induced Mouse Model of Gastrointestinal Disorder
por: Selvaraj, Divya Bharathi, et al.
Publicado: (2023) -
A Mild Dose of Aspirin Promotes Hippocampal Neurogenesis and Working Memory in Experimental Ageing Mice
por: Vergil Andrews, Jemi Feiona, et al.
Publicado: (2023) -
COVID-19 and Parkinson’s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia
por: Rethinavel, Harini Sri, et al.
Publicado: (2021) -
A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009) -
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
por: Liang, Hong, et al.
Publicado: (2021)